Equities
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (EUR)86.28
  • Today's Change0.29 / 0.34%
  • Shares traded112.00
  • 1 Year change+22.30%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 07:07 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Colgate-Palmolive Company manufactures a range of products for the personal and home care markets. It operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care product segment is managed geographically in five segments, such as North America, Latin America, Europe, Asia Pacific and Africa/Eurasia, all of which sell primarily to a variety of traditional and e-commerce retailers, wholesalers, distributors, dentists and skin health professionals. The Company sells its products under brands, such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom’s of Maine, EltaMD, Filorga, Irish Spring, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Soupline and Suavitel, as well as Hill’s Science Diet and Hill’s Prescription Diet. Through Hill's Pet Nutrition, it is also engaged in the pet nutrition market, selling products principally through authorized pet supply retailers, veterinarians and e-commerce retailers.

  • Revenue in USD (TTM)20.11bn
  • Net income in USD2.87bn
  • Incorporated1923
  • Employees34.00k
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.